Cancer of the Ovary Outlook
What to expect with ovarian cancer:
- About 75 percent of women diagnosed with ovarian cancer will survive longer than 5 years if their cancers are treated before the cancer has spread beyond the ovaries.
- If the cancer has spread to nearby regions in the pelvis, the survival rate drops to 50 percent.
- If the cancer has spread to sites outside the pelvis, the survival rate is only 10 percent.
Continue to Cancer of the Ovary Complications
- Boente MP, Hamilton TC, Godwin AK, Buetow K, Kohler MF, Hogan WM, Berchuck A, Young RC. Early ovarian cancer: a review of its genetic and biologic factors, detection, and treatment. Curr Probl Cancer. 1996 Mar-Apr;20(2):83-137. 
- Johnston SR. Ovarian cancer: review of the National Institute for Clinical Excellence (NICE) guidance recommendations. Cancer Invest. 2004;22(5):730-42. 
- Rosen B, Kwon J, Fung Kee Fung M, Gagliardi A, Chambers A; Cancer Care Ontario's Practice Guidelines Initiative Gynecology Cancer Disease Site Group. Systematic review of management options for women with a hereditary predisposition to ovarian cancer. Gynecol Oncol. 2004 May;93(2):280-6. 
- Wolf JK, Jenkins AD. Gene therapy for ovarian cancer (review). Int J Oncol. 2002 Sep;21(3):461-8. 
- Young M, Plosker GL. Paclitaxel: a pharmacoeconomic review of its use in the treatment of ovarian cancer. Pharmacoeconomics. 2001;19(12):1227-59.